Eli Lilly began reporting payments for speaking, consulting, patient education programs and international education programs as of January 2009. Its first report included the total number of activities each doctor took part in, but that was removed in subsequent reports. In 2010, it added certain travel related expenses. In 2011, it added spending on research and meals. Lilly combines business travel and educational items into one category. Lilly maintains a separate log of payments to health professionals who are not doctors and is the only company to do so. Those payments are also included in Dollars for Docs.
Eli Lilly's 2013 U.S. sales: $15.3 billion. Source: IMS Health.
See all Eli Lilly payments, or visit Eli Lilly's transparency page.
Notable drugs
- Cymbalta (depression, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic osteoarthritis pain, chronic low back pain)
- Humalog (diabetes)
- Alimta (lung cancer, mesothelioma)
- Evista (osteoporosis, lowering risk of invasive breast cancer)
- Cialis (erectile dysfunction, benign prostatic hyperplasia)
- Humulin (diabetes)
- Forteo (osteoporosis)
- Strattera (ADHD)
- Effient (prevents strokes and heart attacks in patients who need to have a heart procedure called percutaneous coronary intervention)
- Glucagon (hypoglycemia, diabetes)
- Erbitux (colon cancer, advanced head and neck cancer)
Payment Reports
2009 Jan. to Dec.
|
Avg. Quarterly |
Total |
| Speaking |
$17,164,168 |
$68,656,671 |
| Other |
$1,914,850 |
$7,659,398 |
| Consulting |
$1,319,715 |
$5,278,860 |
|
$20,398,732 |
$81,594,929 |
2010 Jan. to Dec.
|
Avg. Quarterly |
Total |
| Speaking |
$15,369,387 |
$61,477,547 |
| Other |
$1,766,455 |
$7,065,820 |
| Travel |
$1,301,385 |
$5,205,539 |
| Consulting |
$1,028,629 |
$4,114,517 |
|
$19,465,856 |
$77,863,423 |
2011 Jan. to Dec.
|
Avg. Quarterly |
Total |
| Research |
$37,493,283 |
$149,973,132 |
| Speaking |
$11,857,521 |
$47,430,082 |
| Meals |
$2,887,232 |
$11,548,929 |
| Travel |
$1,683,754 |
$6,735,014 |
| Consulting |
$469,597 |
$1,878,386 |
| Adjustment |
-$5,280 |
-$21,119 |
|
$54,386,106 |
$217,544,424 |
2011 Jan. to Dec. Other Healthcare Professionals
|
Avg. Quarterly |
Total |
| Consulting |
$1,405,186 |
$5,620,743 |
| Other |
$1,147,187 |
$4,588,746 |
| Travel |
$375,318 |
$1,501,272 |
| Speaking |
$126,375 |
$505,501 |
|
$3,054,066 |
$12,216,262 |
2012 Jan. to Dec.
|
Avg. Quarterly |
Total |
| Research |
$45,377,011 |
$181,508,042 |
| Speaking |
$4,713,905 |
$18,855,621 |
| Meals |
$1,840,716 |
$7,362,864 |
| Travel |
$717,795 |
$2,871,178 |
| Consulting |
$484,456 |
$1,937,823 |
| Adjustment |
-$5,310 |
-$21,241 |
|
$53,128,572 |
$212,514,287 |
2012 Jan. to Dec. Other Healthcare Professionals
|
Avg. Quarterly |
Total |
| Other |
$709,800 |
$2,839,200 |
| Speaking |
$697,146 |
$2,788,583 |
| Travel |
$263,274 |
$1,053,095 |
| Consulting |
$105,430 |
$421,721 |
| Adjustment |
-$927 |
-$3,707 |
|
$1,774,723 |
$7,098,892 |
2013 Jan. to Dec.
|
Avg. Quarterly |
Total |
| Research |
$43,834,492 |
$175,337,969 |
| Speaking |
$2,844,660 |
$11,378,638 |
| Meals |
$1,285,515 |
$5,142,061 |
| Consulting |
$549,756 |
$2,199,022 |
| Travel/Other |
$483,998 |
$1,935,992 |
| Adjustment |
-$46,550 |
-$186,201 |
|
$48,951,870 |
$195,807,481 |
2013 Jan. to Dec. Other Healthcare Professionals
|
Avg. Quarterly |
Total |
| Speaking |
$724,760 |
$2,899,041 |
| Other |
$702,096 |
$2,808,382 |
| Travel |
$234,334 |
$937,335 |
| Consulting |
$94,569 |
$378,274 |
| Adjustment |
-$156 |
-$623 |
|
$1,755,602 |
$7,022,409 |
